Sorrento COVIDTRAP™(STI-4398) Demonstrates In Preclinical Studies Its Ability To Completely Inhibit SARS-CoV-2 Viral Infection In Vitro

Press/Media: Expert Comment

PeriodJun 5 2020

Media coverage

28

Media coverage